4-IBP (Standard)

[1]Mégalizzi V, et al. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia. 2007 May;9 (5) :358-69.|[2]Bermack JE, et al. Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. Br J Pharmacol. 2001 Oct;134 (3) :691-9.|[3]Debeir O, et al. Videomicroscopic extraction of specific information on cell proliferation and migration in vitro. Exp Cell Res. 2008 Oct 1;314 (16) :2985-98.|[4]Amer MS, et al. Inhibition of endothelial cell Ca²⁺ entry and transient receptor potential channels by Sigma-1 receptor ligands. Br J Pharmacol. 2013 Mar;168 (6) :1445-55.|[5]Mégalizzi V, et al. 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia. 2007 May;9 (5) :358-69. |[6]Liu X, et al. Influence of Trishomocubanes on Sigma Receptor Binding of N- (1-Benzylpiperidin-4-yl) -4-[123I] iodobenzamide In Vivo in the Rat Brain. Medicinal Chemistry, 2005, 1 (1) : 31-38.